Rhenman & Partners Asset Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Rhenman & Partners Asset Management’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-117,265	Closed	-$1.46M	–	96
2019 Q1	$1.46M	Sell	117,265 -389,700	-77%	-$5.21M	0.17%	72
2018 Q4	$5.74M	Sell	506,965 -25,847	-5%	-$405K	0.66%	55
2018 Q3	$9.97M	Buy	532,812 +181,026	+51%	+$4.16M	1%	48
2018 Q2	$9.09M	Buy	351,786 +115,100	+49%	+$2.99M	0.93%	49
2018 Q1	$5.3M	Sell	236,686 -25,000	-10%	-$610K	0.65%	53
2017 Q4	$6.55M	Buy	+261,686	New	+$6.41M	0.89%	46

Other funds holding FLXN

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Rhenman & Partners Asset Management's FLXN Position: Q2 2019 in Review

Rhenman & Partners Asset Management sold out of Flexion Therapeutics, Inc. (FLXN) in Q2 2019, closing a stake of 117,265 shares — an estimated $1.46M sold.

Rhenman & Partners Asset Management first reported a position in FLXN in Q4 2017 and held it in 6 quarters. The position peaked at $9.97M in Q3 2018. 129 funds tracked by Wall St. Rank hold FLXN as of Q2 2019.

Rhenman & Partners Asset Management reported no remaining Flexion Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
Rhenman & Partners Asset Management sold 117,265 Flexion Therapeutics, Inc. shares in Q2 2019, an estimated $1.46M.
Rhenman & Partners Asset Management first reported a position in Flexion Therapeutics, Inc. in Q4 2017 and held it in 6 quarters.
Rhenman & Partners Asset Management's Flexion Therapeutics, Inc. position peaked at $9.97M in Q3 2018.
129 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2019.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2019, filed 22 Jul 2019.